Ocular Therapeutix
OCUL
OCUL
69 hedge funds and large institutions have $60.1M invested in Ocular Therapeutix in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
69
Holders Change
-4
Holders Change %
-5.48%
% of All Funds
1.57%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
11
Increased
19
Reduced
23
Closed
15
Calls
$378K
Puts
$434K
Net Calls
-$56K
Net Calls Change
-$188K
Top Buyers
| 1 |
HP
Hikari Power
Tokyo,
Japan
|
+$356K |
| 2 |
VF
Virtu Financial
New York
|
+$280K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$187K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$171K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$132K |
Top Sellers
| 1 |
CCI
Columbus Circle Investors
|
-$6.63M |
| 2 |
JPMorgan Chase & Co
New York
|
-$1.36M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$926K |
| 4 |
B
Bailard
Foster City,
California
|
-$907K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$522K |
